RN7SL45P

Across TCGA pan-cancer cohorts, RN7SL45P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RN7SL45P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SL45P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL45P expression acts as an unfavorable survival marker, although some lineages such as BRCA and HNSC show a favorable association.

BRCA, MESO, and LUSC are the cancer types where RN7SL45P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	II,III,IV	0.954	0.886	<.001	95	view →
MESO	OS	Tertile	IV	0.204	0.652	.010	36	view →
LUSC	DFS	Tertile	III,IV	0.128	0.774	.002	35	view →
THCA	DFS	Quartile	III,IV	0.512	0.775	.012	23	view →
DLBC	OS	Tertile	II,III,IV	0.323	0.920	.026	21	view →
UCS	DFS	Tertile	All	0.225	0.481	.016	18	view →
KIRP	DFS	Tertile	III,IV	0.520	0.691	.008	18	view →
HNSC	OS	Tertile	III,IV	0.586	0.344	.025	18	view →
ACC	OS	Tertile	All	0.233	0.649	.022	15	view →
LIHC	OS	Tertile	III,IV	0.657	0.261	.010	12	view →
UCEC	DFS	Tertile	II,III,IV	0.741	0.856	.009	10	view →
THYM	DFS	Tertile	II,III,IV	0.729	0.925	.030	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RN7SL45P–BRCA (OS)

Open the BRCA breakdown →